1.
FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES. ISIRJBMS. 2026;3(5):45-55. Accessed November 17, 2026. https://isirpublisher.com/index.php/isirjbms/article/view/48